GlassScriptPhysician profile
Emily C Ager
NPI 1235593880
$1,316.50
in general payments reported to CMS, 2019-2025
12 companies · $282 in 2025
The $282 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.71 · 2020: $33.30 · 2022: $11.71 · 2023: $432 · 2024: $544 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,257.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $364.84 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $234.70 | 2023-2025 | Vraylar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $148.40 | 2023-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $126.80 | 2024-2025 | |
| Amgen INC. | $100.22 | 2023-2024 | Otezla, Repatha |
| Exact Sciences Corporation | $96.03 | 2023-2024 | Cologuard Collection Kit |
| Novo Nordisk INC | $95.21 | 2020-2025 | Ozempic, Rybelsus |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $55.08 | 2024-2025 | Caplyta |
| Xeris Pharmaceuticals, INC. | $42.23 | 2023-2024 | Gvoke Hypopen |
| Astellas Pharma US INC | $25.32 | 2023 | Veozah |
| Pfizer INC. | $15.96 | 2025 | |
| Lilly USA, LLC | $11.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Ager listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.